Exciting Developments at CathWorks for TCT 2025 Conference

Exciting Developments at CathWorks for TCT 2025 Conference
CathWorks, a global front-runner in digital health innovations, is preparing to shine at the Cardiovascular Research Foundation's annual Transcatheter Cardiovascular Therapeutics (TCT) conference. The event, held from October 25 to 28 at a renowned venue, will spotlight the CathWorks FFRangio® System amid numerous scientific sessions, live demonstrations, and key academic programs.
Featured Events and Presentations
The upcoming conference features the CathWorks FFRangio® System in a diverse array of presentations, including cutting-edge abstracts and live case studies. Attendees can expect engaging demonstrations at the CathWorks booth, where innovative FFRangio technology will be showcased through interactive sessions hosted by leading experts.
Scientific Presentations
On the morning of the event, Dr. Kazuhiro Dan from Ichinomiyanishi Hospital will present groundbreaking insights regarding the role of the FFRangio Sizing Tool. His presentation, focusing on the initial report surrounding this revolutionary system and its implications for coronary interventions, promises to provide valuable insights into clinical outcomes.
In the afternoon, Dr. Pedro Carvalho from Minneapolis Heart Institute Foundation will deliver two significant talks, elaborating on the clinical implementation of angiography-derived fractional flow reserve and presenting comparative insights into predictions arising from various imaging methodologies.
Live Case Demonstrations
The live case sessions are poised to attract considerable interest. Dr. William Fearon and Dr. Brian Kim from Stanford Health Care will conduct a live demonstration during an important session focused on intravascular imaging and physiology. This will be followed by another live case, performed by Dr. Margaret McEntergart and her team at Columbia University, showcasing real-time application of the FFRangio system.
Academic Satellite Program
A highlight of the event is the academic satellite program scheduled for Sunday lunchtime. Chaired by Dr. Martin Leon from Columbia University, this session will present findings from the ALL-RISE® study, which features a prestigious panel of physicians sharing the latest evidence on the FFRangio system. The discussions will revolve around the exciting benefits that the FFRangio technology brings to the medical field, equipping healthcare professionals to make informed decisions for managing coronary artery disease.
Corporate Insights
Ramin Mousavi, President and CEO of CathWorks, expressed enthusiasm for the company's prominent presence at the TCT conference. He emphasizes a broader movement towards non-invasive solutions in the field of interventional cardiology, indicating that CathWorks aims to establish the FFRangio system as a new standard in coronary physiology. The feedback from clinical use continues to support this vision, encouraging ongoing collaboration with physician partners.
For those interested, CathWorks welcomes the public to visit booth #1461 during the conference for firsthand experiences with their innovations. This venue will provide an excellent opportunity for attendees to engage with the technology and learn about its practical applications.
About CathWorks
CathWorks is leading the charge in transforming healthcare through digital innovation. The FFRangio® System combines advanced algorithms with ergonomic design, enabling seamless access to physiological data during coronary assessments. This unique technology extracts essential information from standard angiograms and generates real-time data critical for patient treatment strategies, promoting enhanced care without invasive methods.
To learn more about CathWorks and their pioneering work, interested parties are encouraged to visit their website and follow their social media for updates on ongoing research and developments.
Frequently Asked Questions
What is the FFRangio® System?
The FFRangio® System is a digital innovation by CathWorks that extracts physiological data from standard angiograms, offering non-invasive insights into coronary artery disease treatment.
When is the TCT 2025 conference?
The TCT 2025 conference will be held from October 25 to 28 at the Moscone Center.
Who will be presenting at the conference?
Key presentations will feature renowned doctors like Dr. Kazuhiro Dan and Dr. Pedro Carvalho, discussing the FFRangio inventions and clinical experiences.
What can attendees expect from the CathWorks booth?
Attendees can participate in hands-on demonstrations of the FFRangio technology and engage with expert panels on best practices and findings.
Why is the TCT conference important?
The TCT conference is vital for sharing advancements in cardiovascular technologies, fostering collaboration among medical professionals, and enhancing patient care.
About The Author
Contact Olivia Taylor privately here. Or send an email with ATTN: Olivia Taylor as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.